PATENT CLAIM ANALYSIS

Application Number: 16182146
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-02
Patent Classification: ["435", "320100"]

Abstract:
Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.

Claim (Index 12):
The mammalian cell of  claim 10 , wherein said mammalian cell is a primary mammalian cell.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 98.0
- Lexical Diversity: 1.4
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15224151', '15250514', '15818649', '15606995', '15864947']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7181648659255289
- 35 USC 102 Novelty (BERT): 0.5827457737251571
- Combined Prediction Score: 0.7046229567054917
- Mean Citation Score: 450.252034
- Max Citation Score: 687.09875
- Similarity Product: 400.9352040421217

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test